Vitamin D: The Hormone Your Immune System Cannot Function Without

Reclassifying Vitamin D

Vitamin D3 (cholecalciferol) is synthesized in the skin upon UV-B exposure and converted via two hydroxylation steps — first in the liver to 25-hydroxyvitamin D3 [25(OH)D3, the storage form], then in the kidneys and immune cells to 1,25-dihydroxyvitamin D3 [calcitriol, the active form]. Calcitriol binds to the vitamin D receptor (VDR), a nuclear receptor that regulates gene expression in over 200 target genes across more than 30 tissue types — making Vitamin D a steroid hormone, not a simple micronutrient.

Optimal vs 'Normal': The Clinical Gap

Conventional laboratory reference ranges classify serum 25(OH)D below 20 ng/mL as deficient and 20–30 ng/mL as insufficient. Functional medicine and longevity clinicians recognize this as woefully inadequate. Population studies consistently show that optimal immune and cardiovascular outcomes occur at 50–80 ng/mL. Functional medicine practitioners increasingly recommend a target of 40–60 ng/mL to support optimal immune and cardiovascular function.

Global prevalence of suboptimal Vitamin D (<30 ng/mL) is estimated at 40–50% in the general population, rising to 80%+ in populations with limited sun exposure, darker skin tones, or high rates of indoor work (Forrest & Stuhldreher, 2011, Nutrition Research).

Immune Regulation: The COVID-19 Lesson

Vitamin D is perhaps most critical for innate immune function. VDR activation in macrophages and dendritic cells induces the production of antimicrobial peptides (cathelicidin, β-defensins), enhances phagocytosis, and critically, regulates inflammatory cytokine storms. This mechanistic foundation explains why observational data consistently shows that low Vitamin D correlates with increased susceptibility to respiratory infections, and why the most severe COVID-19 outcomes occurred disproportionately in Vitamin D deficient patients (Martineau et al., 2017 meta-analysis, BMJ).

K2: The Critical Co-Factor

AXEL's Lipo® formulations always combine D3 with K2 (as MK-7) — recognizing that D3 supplementation increases calcium absorption, and without K2 to direct calcium into bone (via osteocalcin activation) and out of arteries (via Matrix Gla Protein activation), supplemental D3 can paradoxically increase arterial calcification risk. This combination is now considered the standard of care in functional medicine vitamin D protocols.